Changeflow GovPing Pharma & Healthcare ML/AI Model Predicts Head and Neck Cancerous Le...
Routine Notice Added Final

ML/AI Model Predicts Head and Neck Cancerous Lesion Risk

Favicon for changeflow.com ClinicalTrials.gov Studies
Published
Detected
Email

Summary

NIH registered ClinicalTrials.gov study NCT07532538, an observational multi-center trial to develop and validate a deep learning/AI-based clinical prediction model for head and neck cancerous lesion risk. The study targets hypopharyngeal cancer, laryngeal cancer, and general head and neck cancer. The trial is registered as an observational study without stated enrollment or completion dates.

Published by NIH on changeflow.com . Detected, standardized, and enriched by GovPing. Review our methodology and editorial standards .

What changed

NIH registered study NCT07532538 on ClinicalTrials.gov, posting an observational trial to develop and validate an AI/deep learning model for predicting head and neck cancerous lesion risk. The study uses multi-center clinical data and focuses on hypopharyngeal cancer, laryngeal cancer, and head and neck cancer conditions.

Healthcare providers, clinical investigators, and oncology researchers should note this registry entry represents academic medical research activity rather than a regulatory compliance requirement. Trial sponsors and research institutions conducting similar cancer prediction studies may find this relevant for understanding ongoing research landscape.

Archived snapshot

Apr 16, 2026

GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.

← ClinicalTrials.gov Studies

A Machine Learning-Based Risk Prediction Model for Head and Neck Cancerous Lesions

Observational NCT07532538 Kind: OBSERVATIONAL Apr 16, 2026

Abstract

This study aims to develop and validate a clinical prediction model for the risk of head and neck cancerous lesions using deep learning combined with AI algorithms, based on multi-center clinical data.

Conditions: Hypopharyngeal Cancer, Laryngeal Cancer, Head and Neck Cancer

View original document →

Get daily alerts for ClinicalTrials.gov Studies

Daily digest delivered to your inbox.

Free. Unsubscribe anytime.

About this page

What is GovPing?

Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission

What's from the agency?

Source document text, dates, docket IDs, and authority are extracted directly from NIH.

What's AI-generated?

The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.

Last updated

Classification

Agency
NIH
Published
April 16th, 2026
Instrument
Notice
Legal weight
Non-binding
Stage
Final
Change scope
Minor
Document ID
NCT07532538

Who this affects

Applies to
Healthcare providers Clinical investigators Pharmaceutical companies
Industry sector
5417 Scientific Research
Activity scope
Clinical trial registration Medical research AI model development
Geographic scope
United States US

Taxonomy

Primary area
Healthcare
Operational domain
Clinical Operations
Topics
Pharmaceuticals Medical Devices Public Health

Get alerts for this source

We'll email you when ClinicalTrials.gov Studies publishes new changes.

Free. Unsubscribe anytime.

You're subscribed!